The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Arcutis Biotherapeutics Inc (NASDAQ: ARQT) was $8.47 for the day, down -1.40% from the previous closing price of $8.59. In other words, the price has decreased by -$1.40 from its previous closing price. On the day, 2.16 million shares were traded. ARQT stock price reached its highest trading level at $8.85 during the session, while it also had its lowest trading level at $8.38.
Ratios:
Our analysis of ARQT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.80 and its Current Ratio is at 7.08. In the meantime, Its Debt-to-Equity ratio is 2.32 whereas as Long-Term Debt/Eq ratio is at 2.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on January 03, 2024, Upgraded its rating to Buy and sets its target price to $8 from $4 previously.
On October 26, 2023, Mizuho Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $57 to $4.
Goldman Downgraded its Buy to Neutral on October 13, 2023, whereas the target price for the stock was revised from $32 to $6.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 04 ’24 when Heron Patrick J bought 21,052 shares for $9.50 per share. The transaction valued at 199,994 led to the insider holds 8,785,284 shares of the business.
Watanabe Todd Franklin sold 14,903 shares of ARQT for $165,739 on Mar 04 ’24. The insider now owns 874,533 shares after completing the transaction at $11.12 per share. On Mar 04 ’24, another insider, Burnett Patrick, who serves as the insider of the company, sold 4,782 shares for $11.12 each. As a result, the insider received 53,182 and left with 269,300 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARQT now has a Market Capitalization of 973804416 and an Enterprise Value of 754064192. Its current Enterprise Value per Revenue stands at 12.651 whereas that against EBITDA is -3.147.
Stock Price History:
Over the past 52 weeks, ARQT has reached a high of $15.21, while it has fallen to a 52-week low of $1.76. The 50-Day Moving Average of the stock is -16.18%, while the 200-Day Moving Average is calculated to be 30.22%.
Shares Statistics:
ARQT traded an average of 4.39M shares per day over the past three months and 2374110 shares per day over the past ten days. A total of 114.97M shares are outstanding, with a floating share count of 97.27M. Insiders hold about 15.40% of the company’s shares, while institutions hold 84.54% stake in the company. Shares short for ARQT as of 1713139200 were 19662102 with a Short Ratio of 4.48, compared to 1710460800 on 14992514. Therefore, it implies a Short% of Shares Outstanding of 19662102 and a Short% of Float of 20.629998999999998.
